Skip to content
Browse

Edition

Sections

Appearance

AboutSourcesContactPrivacy

We're raising our price target on Cardinal Health after another stellar quarter of profits

The drug distributor also raised its full-year earnings guidance.

First reported by CNBC 1 source
Read at CNBC(opens in a new tab)

Full coverage

Every report we found on this story, oldest first. Each links to the original publisher.

  1. CNBC

    We're raising our price target on Cardinal Health after another stellar quarter of profits (opens CNBC in a new tab)

    The drug distributor also raised its full-year earnings guidance.

Something wrong with how we've grouped or summarised this story? Report a problem